Provided by Tiger Trade Technology Pte. Ltd.

Sanofi SA

43.33
+0.56001.31%
Post-market: 43.330.00000.00%16:10 EDT
Volume:2.33M
Turnover:100.87M
Market Cap:103.82B
PE:23.24
High:43.74
Open:43.70
Low:43.02
Close:42.77
52wk High:52.68
52wk Low:40.89
Shares:2.40B
Float Shares:2.16B
Volume Ratio:1.10
T/O Rate:0.11%
Dividend:2.38
Dividend Rate:5.49%
EPS(TTM):1.86
EPS(LYR):3.76
ROE:5.71%
ROA:5.09%
PB:1.30
PE(LYR):11.53

Loading ...

Movement Alert|Sanofi Rises 3.09% in Pre-Market Trading, First-in-Class Drug Venglustat Granted FDA Priority Review

Market Focus
·
Jun 04

Sanofi's Groundbreaking Drug Venglustat Seeks FDA Approval for Type 3 Gaucher Disease

Stock News
·
May 28

Sanofi announces FDA grants priority review to venglustat new drug application

TIPRANKS
·
May 28

Sanofi Granted FDA Priority Review for Potential Treatment of Rare Gaucher Disease

MT Newswires Live
·
May 28

Sanofi reports ElevAATe trial of efdoralprin alfa meets primary endpoint

TIPRANKS
·
May 19

Regeneron Pharmaceuticals Trial Miss May Raise Broader Strategy Questions, RBC Says

MT Newswires Live
·
May 18

Sanofi’s SAR445399 Lung Trial Moves Ahead: What Investors Should Watch

TIPRANKS
·
May 15

Google AI legend raises big money for startup targeting this cutting-edge goal

Dow Jones
·
May 13

Global Pharmaceutical Giants Report Robust Earnings, Increasing Investments in China

Deep News
·
May 07

Sanofi Needs Acquisitions to Overcome Pipeline Disappointments -- Market Talk

Dow Jones
·
May 07

Regeneron, Sanofi present results from Dupixent Phase 4 trial

TIPRANKS
·
May 05

Sanofi appoints Belén Garijo CEO, effective May 1, 2026

Reuters
·
May 05

Sanofi invests C$294M to expand AI Center of Excellence in Toronto

TIPRANKS
·
May 05

European Equities Traded in the US as American Depositary Receipts Start Week Lower

MT Newswires Live
·
May 04

Regeneron Flags FDA Delays For Eylea HD Prefilled Syringe

Benzinga Earnings
·
Apr 30

Sanofi appoints Belén Garijo CEO, effective May 1

Reuters
·
Apr 30

Regeneron Earnings Beat Expectations. Upcoming Cancer Data Matter More for the Stock. -- Barrons.com

Dow Jones
·
Apr 29

Sanofi's New CEO Needs to Be Clear on Strategy -- Market Talk

Dow Jones
·
Apr 27

Sector Update: Health Care

MT Newswires Live
·
Apr 25

Sanofi Prices $2.7 Billion in Bonds in Three-Part Offering

MT Newswires Live
·
Apr 25